$MNST

Wells Fargo raised Monster Beverage's (MNST) price target to $50.00, citing strong Q3 expectations and global revenue growth. The stock trades at $46.19, near its 52-week high. Analysts highlight Monster's innovation, mid-single-digit growth prospects, and strong gross profit margins, despite a high P/E ratio. Earnings are due soon. Other analysts also maintain positive outlooks, and the company plans new product launches. InvestingPro data suggests the stock may be overvalued.

JPMorgan lowered its price target for Monster Beverage from $99 to $49. The stock is currently trading at $46.19, up 20.49% year-to-date. The adjustment may impact investor sentiment and trading activity.

Monster Beverage reported $2.5B in Q2 sales, a first, with international business driving 35% YoY growth, now 46% of total revenue. The company shows resilience amid inflation, leveraging its global distribution network.

Analysts updated ratings and price targets for several companies. Block (SQ) was upgraded to outperform with a target raised to $101. Halliburton (HAL) was upgraded to buy with a target increased to $40. Tesla (TSLA) was upgraded to hold with a target raised to $400. Other companies mentioned include Qiagen (QGEN), CoreWeave (CWV), and Meta (META).

Piper Sandler reiterated an Overweight rating and $50.50 price target for Monster Beverage (MNST), citing energy drink category growth and strong teen adoption. MNST stock is up 19% YTD and 30% over the past year. The company reported Q2 2026 earnings of $0.60 per share on $2.54B revenue, beating estimates, and plans a new protein energy line for 2027.

Analysts updated ratings and price targets for several companies. Notable changes include Datadog (DDOG) upgraded to outperform with a raised target to $350, Intel (INTC) upgraded to neutral with a $85 target, and MGM Resorts (MGM) maintained as underweight with a reduced target to $29. Other companies affected include Boyd Gaming (BYD), Bxp (BXP), and Fair Isaac (FICO).

UBS lowered its price target for Monster Beverage from $53 to $49, while maintaining a neutral rating. The stock has seen a 5-day change of +2.61% and a year-to-date increase of +18.27%.

Monster Energy plans to launch Monster + Protein, a canned protein shake with 30g protein and 160mg caffeine, in 2027. The drink, available in chocolate and vanilla, re-enters a market Monster exited in 2017. The company also plans new Monster energy drink flavors and espresso offerings. Monster aims to leverage innovation to attract new consumers, as highlighted in recent earnings calls.

Vita Coco raised full-year guidance but its stock fell 22.1% post-earnings. Celsius reported $817.9M revenue, missing estimates, and its stock dropped 2%. Philip Morris reported $11.19B revenue, beating estimates, and its stock rose 7.1%. Boston Beer's revenue fell 3.3%, missing EPS estimates, and its stock declined 2.3%.

Citi analysts noted subdued conditions in convenience and fuel retailing, citing higher gas prices and lower-income consumer pressure. Monster Beverage (MNST) and Celsius Holdings (CELH) showcased new product lines. Coca-Cola (KO), PepsiCo (PEP), and Keurig Dr Pepper (KDP) announced new beverage launches. Molson Coors (TAP), Constellation Brands (STZ), and Boston Beer (SAM) also presented new offerings.